Skip to main content

Experience the Difference with the AeroChamber* Brand of Spacers 

Contact Us to Learn More

Image
AeroChamber VHC with inhaler sitting in front of generic spacer cut-outs

 

The Most Studied Brand of Spacer1

Designed with Patients in Mind

The AEROCHAMBER PLUS* FLOW-VU* Spacer is designed with patient-inspired features.

Image
Flow-Vu indicator in motion

See the Difference

The FLOW-VU* Inhalation Indicator moves toward the patient as they inhale, allowing them to coordinate actuation with inhalation.

Image
Flow-Vu whistle

Hear the Difference

The FLOWSIGNAL* Whistle alerts patient to breathe slowly. 

(Not available on Pediatric mask models)

Image
Comfort Seal mask

Feel the Difference

The COMFORTSEAL* Mask contours gently to the face, providing a secure seal and comfortable fit.2


 

The AEROCHAMBER* Brand of Spacers

Image
Badge of safety validation

Most Studied

The safety and efficacy is validated in numerous third-party clinical evaluations with different patient populations with different pMDIs, including safety data for infants.3

Image
Winning ribbon

Most Recommended

The AEROCHAMBER PLUS* brand of spacers is the most recommended for use with leading Metered Dose Inhalers (MDIs).4


Spacers for All Age Groups

The AEROCHAMBER PLUS* FLOW-VU* Spacer is available in a range of sizes for children and adults from 0 months to 80+ years, including an on-the-go option.

Image
AeroChamber Brand family of products

Spacer and Inhaler: Always Together

Image
Lung deposition illustration with and without spacer

 

People who use a spacer, such as an AEROCHAMBER PLUS* FLOW-VU* Spacer, with their inhaler have been shown to have better control of their respiratory symptoms.5

That's why respiratory guidelines - including the Australian Asthma Handbook - recommend the use of chambers when using metered dose inhalers or puffers in people of all ages.6,7,8

Access the Australian Asthma Handbook

 

Using an AEROCHAMBER PLUS* FLOW-VU* Spacer with inhaler helps:

Improve Medication Delivery

Helps consistently deliver the intended dose of medication to the lungs, regardless of inhaler technique.9

Allow More Time to Inhale Medication

Holds the medication suspended for an extended period of time, helping to overcome coordination issues.10

Reduce Potential Side Effects

Limits the amount of medication that ends up in the back of the throat, causing hoarseness, sore throat or thrush.11,12,13,14


Contact Us

Complete the form below to get in touch with a member of our team.

 

Related Products

Image
Z Stat

AEROCHAMBER PLUS* Z STAT* Spacer

Single patient use chamber intended for hospital.

View product.

Image
Aerobika OPEP Device

AEROBIKA* OPEP Device

Drug-free Oscillating Positive Expiratory Pressure (OPEP) device for airway clearance.

View product.

Image
AeroEclipse II BAN Nebulizer

AEROECLIPSE* II BAN* Nebulizer

Breath Actuated delivery for true on-demand therapy.

View product.


 

About Us

Trudell Medical Australia

Trudell Medical Australia Pty. Ltd. is an affiliate of Trudell Medical International (TMI), a global leader in aerosol drug delivery and lung health devices for the management of respiratory conditions. 

Headquartered in London, Canada, we design and manufacture high-quality products sold in over 100 countries. Our devices are backed by science and supported with over 100 peer-reviewed articles and over 300 patents. By focusing on clinical utility, innovation and unique patient-centric design, we are on a mission to help people breathe better and live fuller lives.


References
  1. GPrX Prescription Data [August 2023]
  2. Shah SA et al. Force-Dependent Static Dead Space of Face Masks Used With Holding Chambers. Respiratory Care, February 2006, Vol 51; No 2
  3. Study Summary, AeroChamber* Brand of Chambers, June 2024. Pulmonary and Therapeutics 2018 Oct;52:8-17
  4. GPrX Prescription Data [August 2023]
  5. Levy ML et al. Asthma patients' inability to use a pressurized metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the Global Initiative for Asthma (GINA) strategy: a retrospective analysis. Prim Care Respir J. 2013; Dec; 22(4):406-11
  6. Canadian Thoracic Society - 2010 Consensus Summary for children six years of age and over, and adults.
  7. Global Initiative for Asthma 2020
  8. The Australian Asthma Handbook (Version 2.1 2020)
  9. Dorinsky P et al. Relative Bioavailability of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Administered With and Without a Spacer: Results of a Phase I, Randomized, Crossover Trial in Healthy Adults. Clin Ther. 42 (2020), 634-648.
  10. Suggett J et al. The impact of inhalation delay on lung drug delivery: using functional respiratory imaging (FRI) to compare metered dose inhaler (MDI) and MDI/Valved Holding Chamber (VHC) Systems. Am J Respir Crit Care Med 2020;201:A5889.
  11. Canadian Thoracic Society – 2010 Consensus Summary for children six years of age and over, and adults.
  12. Global Strategy for Asthma Management and Prevention 2021 (Global Initiative on Asthma) (www.ginasthma.com)
  13. Suggett J et al. Assessment of potential mouth/ throat deposition and lung delivery of suspension-and solution-formulated inhaled corticosteroid formulations delivered by pressurized metered dose inhaler without and with valved holding chamber using an anatomic adult upper airway. Drug Delivery to the Lungs 28, Dec 2017.
  14. Suggett J et al. A Comparison, Using Functional Respiratory Imaging (FRI), of Adult Airway Deposition Profiles from a Pressurized Metered Dose Inhaler with Valved Holding Chamber (pMDI/VHC) and Two Dry Powder Inhalers (DPI). Respiratory Drug Delivery 2021.